Detalhe da pesquisa
1.
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma.
Br J Haematol
; 184(4): 524-535, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575016
2.
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Haematologica
; 103(9): 1511-1517, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880613
3.
Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.
Haematologica
; 106(1): 284-287, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079693
4.
A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib.
Blood
; 130(14): 1676-1679, 2017 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28794071
5.
Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia.
Blood Adv
; 7(17): 4728-4737, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516082
6.
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
Blood Adv
; 7(16): 4528-4538, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026796
7.
Outcomes and factors impacting use of axicabtagene ciloleucel in patients with relapsed or refractory large B-cell lymphoma: results from an intention-to-treat analysis.
Leuk Lymphoma
; 62(6): 1344-1352, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375873
8.
Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis.
Clin Lymphoma Myeloma Leuk
; 21(3): 170-175, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431309
9.
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.
Clin Cancer Res
; 26(14): 3589-3596, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32198151
10.
Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.
Clin Cancer Res
; 25(14): 4264-4270, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004001
11.
A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.
Blood Adv
; 3(10): 1568-1573, 2019 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31101647
12.
Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel.
Bone Marrow Transplant
; 58(5): 590-593, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774431
13.
Evaluation of pre-transplant risk assessments in allogeneic hematopoietic cell transplant.
Bone Marrow Transplant
; 57(6): 1031-1033, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428866
14.
Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy.
Blood Adv
; 3(2): 132-135, 2019 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651281